US 10973862
Bifidobacterium longum for treating obesity and associated metabolic disorders
granted A61KA61K35/745A61P
Quick answer
US patent 10973862 (Bifidobacterium longum for treating obesity and associated metabolic disorders) held by PrecisionBiotics Group Limited expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrecisionBiotics Group Limited
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/745, A61P, A61P3/04